Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
The Company is in ongoing dialogue with the FDA regarding the submission of a Biologics License Appl
The Company is in ongoing dialogue with the FDA regarding the submission of a Biologics License Appl